SPECTRA7 MICROSYSTEMS INC (SEV.CA) Fundamental Analysis & Valuation

TSX-V:SEV • CA84761T8692

0.01 CAD
0 (0%)
Last: Apr 28, 2025, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This SEV.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to SEV. SEV was compared to 3 industry peers in the Semiconductors & Semiconductor Equipment industry. The financial health of SEV is average, but there are quite some concerns on its profitability. SEV does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

2

1. SEV.CA Profitability Analysis

1.1 Basic Checks

  • SEV had negative earnings in the past year.
  • SEV had a negative operating cash flow in the past year.
  • SEV had negative earnings in each of the past 5 years.
  • In the past 5 years SEV always reported negative operating cash flow.
SEV.CA Yearly Net Income VS EBIT VS OCF VS FCFSEV.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 -5M -10M -15M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -191.17%, SEV is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
  • SEV has a better Return On Equity (-241.65%) than 100.00% of its industry peers.
Industry RankSector Rank
ROA -191.17%
ROE -241.65%
ROIC N/A
ROA(3y)-76.15%
ROA(5y)-249.22%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SEV.CA Yearly ROA, ROE, ROICSEV.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 -500 -1K -1.5K

1.3 Margins

  • SEV's Gross Margin of 41.85% is amongst the best of the industry. SEV outperforms 100.00% of its industry peers.
  • In the last couple of years the Gross Margin of SEV has remained more or less at the same level.
  • SEV does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 41.85%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.71%
GM growth 5Y1.44%
SEV.CA Yearly Profit, Operating, Gross MarginsSEV.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 -200 -400

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. SEV.CA Health Analysis

2.1 Basic Checks

  • SEV does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • SEV has more shares outstanding than it did 1 year ago.
  • Compared to 1 year ago, SEV has a worse debt to assets ratio.
SEV.CA Yearly Shares OutstandingSEV.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M
SEV.CA Yearly Total Debt VS Total AssetsSEV.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M

2.2 Solvency

  • SEV has an Altman-Z score of -28.61. This is a bad value and indicates that SEV is not financially healthy and even has some risk of bankruptcy.
  • SEV has a Altman-Z score of -28.61. This is in the lower half of the industry: SEV underperforms 66.67% of its industry peers.
  • There is no outstanding debt for SEV. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -28.61
ROIC/WACCN/A
WACC10.28%
SEV.CA Yearly LT Debt VS Equity VS FCFSEV.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 5M -5M -10M

2.3 Liquidity

  • SEV has a Current Ratio of 4.19. This indicates that SEV is financially healthy and has no problem in meeting its short term obligations.
  • SEV has a better Current ratio (4.19) than 100.00% of its industry peers.
  • A Quick Ratio of 3.29 indicates that SEV has no problem at all paying its short term obligations.
  • With an excellent Quick ratio value of 3.29, SEV belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.19
Quick Ratio 3.29
SEV.CA Yearly Current Assets VS Current LiabilitesSEV.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. SEV.CA Growth Analysis

3.1 Past

  • SEV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -119.56%.
  • SEV shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -82.70%.
  • SEV shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 18.58% yearly.
EPS 1Y (TTM)-119.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%53.85%
Revenue 1Y (TTM)-82.7%
Revenue growth 3Y112.46%
Revenue growth 5Y18.58%
Sales Q2Q%-95.17%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y100%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year66.25%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SEV.CA Yearly Revenue VS EstimatesSEV.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B
SEV.CA Yearly EPS VS EstimatesSEV.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2022 2023 -1 -2 -3 -4 -5

More info and screens

Find the best growth stocksShow best growing peers

0

4. SEV.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • SEV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SEV.CA Price Earnings VS Forward Price EarningsSEV.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SEV.CA Per share dataSEV.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 -0.05 -0.1 -0.15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. SEV.CA Dividend Analysis

5.1 Amount

  • SEV does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

SEV.CA Fundamentals: All Metrics, Ratios and Statistics

SPECTRA7 MICROSYSTEMS INC

TSX-V:SEV (4/28/2025, 7:00:00 PM)

0.01

0 (0%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)06-07
Earnings (Next)N/A
Inst Owners28.38%
Inst Owner ChangeN/A
Ins Owners12.45%
Ins Owner ChangeN/A
Market Cap1.59M
Revenue(TTM)2.17M
Net Income(TTM)-18.35M
Analysts84.44
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.53
P/FCF N/A
P/OCF N/A
P/B 0.15
P/tB 0.17
EV/EBITDA N/A
EPS(TTM)-0.19
EYN/A
EPS(NY)0
Fwd EYN/A
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)-0.05
OCFYN/A
SpS0.02
BVpS0.07
TBVpS0.06
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -191.17%
ROE -241.65%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 41.85%
FCFM N/A
ROA(3y)-76.15%
ROA(5y)-249.22%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.71%
GM growth 5Y1.44%
F-Score2
Asset Turnover0.23
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 61.64%
Cap/Sales 32.47%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.19
Quick Ratio 3.29
Altman-Z -28.61
F-Score2
WACC10.28%
ROIC/WACCN/A
Cap/Depr(3y)82.34%
Cap/Depr(5y)58.62%
Cap/Sales(3y)8.89%
Cap/Sales(5y)8.2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-119.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%53.85%
EPS Next Y100%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-82.7%
Revenue growth 3Y112.46%
Revenue growth 5Y18.58%
Sales Q2Q%-95.17%
Revenue Next Year66.25%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-201.16%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year6.18%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y33.85%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y36.99%
OCF growth 3YN/A
OCF growth 5YN/A

SPECTRA7 MICROSYSTEMS INC / SEV.CA FAQ

Can you provide the ChartMill fundamental rating for SPECTRA7 MICROSYSTEMS INC?

ChartMill assigns a fundamental rating of 3 / 10 to SEV.CA.


What is the valuation status of SPECTRA7 MICROSYSTEMS INC (SEV.CA) stock?

ChartMill assigns a valuation rating of 0 / 10 to SPECTRA7 MICROSYSTEMS INC (SEV.CA). This can be considered as Overvalued.


What is the profitability of SEV stock?

SPECTRA7 MICROSYSTEMS INC (SEV.CA) has a profitability rating of 2 / 10.


How financially healthy is SPECTRA7 MICROSYSTEMS INC?

The financial health rating of SPECTRA7 MICROSYSTEMS INC (SEV.CA) is 6 / 10.